A new fungal immunomodulatory protein (Fip) has been purified from the
edible mushroom, Volvariella volvacea, and designated Fip-vvo. Analys
is of the purified protein by SDS/PAGE followed by Coomassie Blue stai
ning demonstrated that Fip-vvo is a single polypeptide with an apparen
t molecular mass of 15 kDa. Periodic acid/Schiff staining showed that
this single polypeptide lacks carbohydrates. Using an in vitro bioassa
y measuring blast-formation stimulatory activity, Fip-vvo was shown to
stimulate the maximum proliferation of human peripheral blood lymphoc
ytes at a concentration of 5 mu g/ml. Fip-vvo was capable of agglutina
ting rat red blood cells. Neither haemagglutination nor mitogenic acti
vities were inhibited by mono- or dimeric sugars. In vivo, repeat admi
nistration of Fip-vvo greatly reduced the production of BSA-induced Ar
thus reaction in mice, whereas little effect was observed on the preve
ntion of systemic anaphylaxis reactions. The selectively enhanced tran
scriptional expression of interleukin (IL)-2, IL-4, interferon-gamma,
tumour necrosis factor-a, lymphotoxin and IL-2 receptor by Fip-vvo was
also demonstrated by reverse transcriptase-PCR. This finding suggests
that Fip-vvo exerts its immunomodulatory effects via cytokine regulat
ion. In addition, the complete amino acid sequence of Fip-vvo was obta
ined by direct protein sequencing. This protein consists of 112 amino
acid residues with a blocked N-terminal end and has a calculated molec
ular mass of 12667 Da not including the N-terminal blocking group. By
gel filtration analysis, Fip-vvo exhibited a molecular mass of 26 kDa
for the native molecules in PBS. This result indicates that native Fip
-vvo is most likely a non-covalently associated homodimeric molecule.